Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum INVO Bioscience Inc INVO

INVO Bioscience, Inc. is a healthcare services fertility company. The Company is focused on expanding the assisted reproductive technology (ART) marketplace by making fertility care accessible and inclusive to people around the world. The Company’s flagship product is INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body.... see more

NDAQ:INVO - Post Discussion

INVO Bioscience Inc > Crude Oil Dips 3%; U.S. Bancorp Profit Tops Views | Benzinga
View:
Post by whytestocks on Apr 17, 2024 3:00pm

Crude Oil Dips 3%; U.S. Bancorp Profit Tops Views | Benzinga

JUST IN: $INVO Crude Oil Dips 3%; U.S. Bancorp Profit Tops Views | BenzingaU.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Wednesday.The Dow traded up 0.04% to...INVO - Crude Oil Dips 3%; U.S. Bancorp Profit Tops Views | Benzinga
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities